Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Santa Monica, California and other locations
Dates
study started
completion around

Description

Summary

The 'CRS validation project' consists of a joint effort of 32 medical centers in Europe, the USA, and South Africa to carry out the validation of 2 novel questionnaires designated to measure self-perceived severity and control of Chronic Rhinosinusitis (with or without nasal polyps).

This study will validate translated versions of the same set of questionnaires simultaneously in the centers involved after recruiting a total of 1000 patients, while data collection, statistical analysis, and creation of the study report will be carried out by the statistical department of the University of Leuven.

Patients will be recruited from the regular ENT practice of their hospital to minimize the complexity of the study.

Details

The objectives of this study are as follows:

  • Validation of two new questionnaires with the aim of measuring the current perceived condition of a patient with chronic rhinosinusitis in terms of control and severity.
  • Validation of these questionnaires in routine medical settings.
  • Evaluation of the results of these questionnaires in comparison with other tools currently available.

Keywords

Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps, Rhinosinusitis, Nasal Polyps

Eligibility

You can join if…

Open to people ages 18 years and up

  • Patient capable of giving informed consent
  • Diagnosis of chronic rhinosinusitis with or without nasal polyposis according to the EPOS guidelines
  • No recent sinus surgery (within the last three months)

You CAN'T join if...

  • Not capable of giving informed consent
  • No CRS
  • Recent sinus surgery (within the last three months)

Locations

  • UCLA Santa Monica Medical Center accepting new patients
    Santa Monica California 90401 United States
  • Northwestern University Feinberg School of Medicine accepting new patients
    Chicago Illinois 60208 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
The European Forum for Research and Education in Allergy and Airway Diseases
ID
NCT06970977
Study Type
Observational
Participants
Expecting 1000 study participants
Last Updated